{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:30:41Z","timestamp":1790958641961,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30472001"],"award-info":[{"award-number":["30472001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Planning Project of Guangdong Province, China","award":["2010B011000005"],"award-info":[{"award-number":["2010B011000005"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province, China","award":["A2009412"],"award-info":[{"award-number":["A2009412"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.intimp.2012.12.031","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T17:30:58Z","timestamp":1359048658000},"page":"646-653","source":"Crossref","is-referenced-by-count":15,"title":["Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration"],"prefix":"10.1016","volume":"15","author":[{"given":"Congwen","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2012.12.031_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.1979.tb47100.x","article-title":"T-lymphocyte maturation: cell surface markers and immune functions induced by T-lymphocyte cell-free products and thymosin polypeptides","volume":"332","author":"Ahmed","year":"1979","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2893.2003.00470.x","article-title":"Thymosin alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial","volume":"11","author":"Andreone","year":"2004","journal-title":"J Viral Hepat"},{"issue":"Pt 1","key":"10.1016\/j.intimp.2012.12.031_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1099\/13500872-142-1-109","article-title":"A convenient and reproducible method to genetically transform bacteria of the genus Bifidobacterium","volume":"142","author":"Argnani","year":"1996","journal-title":"Microbiology"},{"issue":"11","key":"10.1016\/j.intimp.2012.12.031_bb0020","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/intimm\/dxm097","article-title":"Thymosin alpha1 activates the TLR9\/MyD88\/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo","volume":"19","author":"Bozza","year":"2007","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0025","first-page":"139","article-title":"Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake","volume":"273","author":"Castell","year":"1997","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.intimp.2012.12.031_bb0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2249.2003.02331.x","article-title":"A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy","volume":"134","author":"Chadwick","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2012.12.031_bb9000","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1365-2036.2001.01135.x","article-title":"The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis","volume":"15","author":"Chan","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3920\/BM2009.0012","article-title":"Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action","volume":"1","author":"Dicks","year":"2010","journal-title":"Benefic Microbes"},{"issue":"3","key":"10.1016\/j.intimp.2012.12.031_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00205574","article-title":"Modulation of natural killer activity by thymosin alpha 1 and interferon","volume":"20","author":"Favalli","year":"1985","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.intimp.2012.12.031_bb9005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1196\/annals.1415.044","article-title":"Thymosin alpha 1: from bench to bedside","volume":"1112","author":"Garaci","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.intimp.2012.12.031_bb9010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1521-4141(200003)30:3<778::AID-IMMU778>3.0.CO;2-I","article-title":"Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level","volume":"30","author":"Giuliani","year":"2000","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2012.12.031_bb0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14712598.4.4.559","article-title":"Thymosins: chemistry and biological properties in health and disease","volume":"4","author":"Goldstein","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"10.1016\/j.intimp.2012.12.031_bb0050","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1073\/pnas.74.2.725","article-title":"Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide","volume":"74","author":"Goldstein","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2012.12.031_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1196\/annals.1415.032","article-title":"IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans","volume":"1112","author":"Hadden","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.intimp.2012.12.031_bb0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.intimp.2004.02.008","article-title":"The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha","volume":"4","author":"Huang","year":"2004","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.intimp.2012.12.031_bb0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0885066609333445","article-title":"The rapidly expanding therapeutic role of thymosin \u03b1-1 in the management of gastrointestinal and systemic infectious disorders","volume":"24","author":"Kapoor","year":"2009","journal-title":"J Intensive Care Med"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb9015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0192-0561(90)90064-T","article-title":"Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes","volume":"12","author":"Leichtling","year":"1990","journal-title":"Int J Immunopharmacol"},{"issue":"2","key":"10.1016\/j.intimp.2012.12.031_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000322350","article-title":"Immunomodulatory effects of lactobacillus and Bifidobacterium on both murine and human mitogen-activated T cells","volume":"156","author":"Li","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"issue":"11","key":"10.1016\/j.intimp.2012.12.031_bb0075","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.peptides.2010.07.026","article-title":"Thymosin alpha 1: biological activities, applications and genetic engineering production","volume":"31","author":"Li","year":"2010","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.intimp.2012.12.031_bb0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.cgt.7700530","article-title":"Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth","volume":"10","author":"Li","year":"2003","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0885066608326970","article-title":"A new immunomodulatory therapy for severe sepsis: ulinastatin plus thymosin \u03b1 1","volume":"24","author":"Li","year":"2009","journal-title":"J Intensive Care Med"},{"issue":"4","key":"10.1016\/j.intimp.2012.12.031_bb0090","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ijo.2009.277","article-title":"Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice","volume":"34","author":"Long","year":"2010","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1196\/annals.1415.040","article-title":"Thymosin \u03b11 as a chemopreventive agent in lung and breast cancer","volume":"1112","author":"Moody","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1196\/annals.1415.036","article-title":"Immunopharmacology of thymosin \u03b11 and cytokine synergy","volume":"1112","author":"Naylor","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1196\/annals.1415.025","article-title":"Signaling pathways leading to the activation of IKK and MAPK by thymosin \u03b11","volume":"1112","author":"Peng","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.intimp.2012.12.031_bb0110","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cellbi.2008.07.011","article-title":"Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells","volume":"32","author":"Peng","year":"2008","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.intimp.2012.12.031_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ijc.2910500327","article-title":"Combination therapy with thymosin a1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice","volume":"50","author":"Mastino","year":"1992","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2012.12.031_bb0120","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1182\/blood-2003-11-4036","article-title":"Thymosin \u03b1 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling","volume":"103","author":"Romani","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2012.12.031_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0192-0561(99)00087-9","article-title":"Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin alpha-1","volume":"22","author":"Roy","year":"2000","journal-title":"Int J Immunopharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijfoodmicro.2011.06.003","article-title":"Stanton metabolic activities and probiotic potential of bifidobacteria","volume":"149","author":"Russell","year":"2011","journal-title":"Int J Food Microbiol"},{"issue":"6","key":"10.1016\/j.intimp.2012.12.031_bb0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/14787210.3.6.885","article-title":"Thymalfasin for the treatment of chronic hepatisis C infection","volume":"3","author":"Rustgi","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"10.1016\/j.intimp.2012.12.031_bb0140","first-page":"147","article-title":"A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer","volume":"4","author":"Schulof","year":"1985","journal-title":"J Biol Response Mod"},{"key":"10.1016\/j.intimp.2012.12.031_bb0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1749-6632.2010.05460.x","article-title":"Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof","volume":"1194","author":"Sherman","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"S6","key":"10.1016\/j.intimp.2012.12.031_bb0150","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1111\/j.1440-1746.2004.03635.x","article-title":"Thymalfasin: an immune system enhancer for the treatment of liver disease","volume":"19","author":"Sjogren","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1567-5769(01)00139-4","article-title":"Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1","volume":"2","author":"Sodhi","year":"2002","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1749-6632.2010.05482.x","article-title":"Thymosin alpha 1: past clinical experience and future promise","volume":"1194","author":"Tuthill","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.intimp.2012.12.031_bb0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00199694","article-title":"Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays","volume":"15","author":"Umeda","year":"1983","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"10.1016\/j.intimp.2012.12.031_bb0170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10753-010-9224-1","article-title":"Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study","volume":"34","author":"Wang","year":"2011","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.intimp.2012.12.031_bb0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ajcn\/27.3.276","article-title":"Intestinal absorption of intact proteins in normal and protein-deficient rats","volume":"27","author":"Worthington","year":"1974","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2005.05.012","article-title":"Thymosin-loaded enteric microspheres for oral administration: preparation and in vitro release studies","volume":"301","author":"Yang","year":"2005","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.intimp.2012.12.031_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1590\/S0100-879X2011007500159","article-title":"Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro","volume":"45","author":"Yang","year":"2012","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"10.1016\/j.intimp.2012.12.031_bb0190","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/mp100331r","article-title":"Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum","volume":"8","author":"Yao","year":"2011","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.intimp.2012.12.031_bb0195","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1440-1746.2006.04699.x","article-title":"Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level","volume":"22","author":"Yao","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.intimp.2012.12.031_bb0200","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/1743-422X-8-525","article-title":"Oral administration of IFN-a2b-transformed B. longum protects the Balb\/c mice against coxsackievirus B3-induced myocarditis","volume":"8","author":"Yu","year":"2011","journal-title":"Virol J"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T21:31:23Z","timestamp":1562621483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1567576913000040"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2012.12.031","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}